₹18.63▲0.76%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -11.79 % |
3 Month Return | -5.43 % |
1 Year Return | -10 % |
Market Stats | |
Previous Close | ₹18.49 |
Open | ₹18.35 |
Volume | 21.36K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹15.15Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹15.15 Cr |
P/B Ratio | 1.3 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹15.15 Cr | 13.12% | 0.69 | NA | NA |
![]() | BUY | ₹24,251.56 Cr | 13.4% | 0.53 | NA | NA |
![]() | NA | ₹531.11 Cr | 229.99% | 0.66 | ₹19 Cr | ₹251 Cr |
![]() | BUY | ₹10,461.37 Cr | 2.81% | 0.50 | NA | NA |
![]() | NA | ₹1,037.27 Cr | 301.68% | 0.64 | ₹10 Cr | ₹64 Cr |
Organisation | Ortin Laboratories Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Ortin Laboratories Ltd
Ortin Laboratories reported a net loss of ₹80.4m in FY 2024, with a loss per share of ₹9.89, and revenue of ₹22.8m, down 62% from FY 2023. Shares are down 1.8% from a week ago.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 92.64% to 98.77% in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 172.9%
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 95.9%
Promoter Holding Down
Promoters have decreased holdings from 7.36% to 1.23% in Mar 2024 quarter
Price Dip
In the last 1 month, ORTINLAB stock has moved down by -12.9%
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹21.22Cr | ↑1.82% |
Total Liabilities | ₹10.36Cr | ↑4.86% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -₹0.25Cr | ↓111.63% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 1.23% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 98.77% | 0.00 | |
Others | 0% | 0.00 |
Ortin Laboratories Ltd’s net profit fell -63.33% since last year same period to ₹0.44Cr in the Q1 2012-2013. On a quarterly growth basis, Ortin Laboratories Ltd has generated 122.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2013, Ortin Laboratories Ltd has declared dividend of ₹0.25 - translating a dividend yield of 4.03%.
Read More about DividendsBearish
Neutral
Bullish
Ortin Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Ortin Laboratories Ltd (ORTINLAB) share price today is ₹18.63
Ortin Laboratories Ltd is listed on NSE
Ortin Laboratories Ltd is listed on BSE
Today’s traded volume of Ortin Laboratories Ltd(ORTINLAB) is 21.36K.
Today’s market capitalisation of Ortin Laboratories Ltd(ORTINLAB) is ₹15.15Cr.
Ortin Laboratories Ltd(ORTINLAB | Price |
---|---|
52 Week High | ₹26.35 |
52 Week Low | ₹16.2 |
Ortin Laboratories Ltd(ORTINLAB) share price is ₹18.63. It is down -29.30% from its 52 Week High price of ₹26.35
Ortin Laboratories Ltd(ORTINLAB) share price is ₹18.63. It is up 15.00% from its 52 Week Low price of ₹16.2
Ortin Laboratories Ltd(ORTINLAB | Returns |
---|---|
1 Day Returns | 0.14% |
1 Month Returns | -11.79% |
3 Month Returns | -5.43% |
1 Year Returns | -10% |